4th Exosome Based Therapeutic Development Summit

Built with biopharmaceutical industry insights, this in-person conference will delve into different types of extracellular vesicles (EVs) from various cell sources as a solution to deliver treatments safely and effectively. Learn how to optimize your translational route towards safe and effective clinical development in a broad range of diseases.

With 3 days of unrivaled content and two dedicated tracks, this year's summit will be putting the spotlight on cutting-edge strategies from discovery, translation, and clinical development of modified and unmodified exosomes and EVs, to accelerate this emerging field forward.

Whether you are challenged by characterization, scale-up manufacturing or regulatory considerations of your EVs or simply are looking to optimize your translational route towards safe and effective clinical development, you will find this year's summit your one-stop shop to gain meaningful insights and cutting-edge data.

Tailor-made to showcase the latest innovations and interactively discuss the industry's most important talking points, join 130+ movers and shakers of the field from the likes of Codiak BioSciences, Rion, MDimmune and Aruna Bio at this must-attend summit to successfully optimize, accelerate and scale your extracellular vesicle-based therapeutics towards the first clinical approval.

URLs:
Tickets: https://go.evvnt.com/1153539-2?pid=2809
Brochure: https://go.evvnt.com/1153539-3?pid=2809

Prices:
Drug Developer - Conference + Focus Day (standard rate) - Discounts Available : USD 4946.00,
Drug Developer - Conference Only (standard rate) - Discounts Available : USD 2999.00,
Academic and Research Institute Pricing - Conference + Focus Day (standard rate) - Discounts Available : USD 4246.00,
Academic and Research Institute Pricing - Conference Only  (standard rate) - Discounts Available : USD 2599.00,
Service Provider Pricing - Conference + Focus Day (standard rate) - Discounts Available : USD 5846.00,
Service Provider Pricing - Conference Only (standard rate) - Discounts Available : USD 3599.00

Speakers: Bas WM van Balkom Assistant Professor University Medical Center Utrecht, Christopher Locher CEO  Versatope Therapeutics, Kristin Luther Senior Scientist Vesigen Therapeutics, Stephanie Kronstadt PhD Candidate- Bioengineering University of Maryland, Carlos Salomon Gallo Associate Professor; Head of Exosome Biology Laboratory The University of Queensland, Joana Correia CEO Exogenous Therapeutics, Shiran Shapira Head of Research Laboratory, Health Promotion Center and Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center  Tel-Aviv Sourasky Medical Center, WeiCheng Su COO Exonox Biosciences, Christine Ichim CEO  Florica Therapeutics, Kenneth Marcus Professor of Chemistry Clemson University, Spencer Marsh CSO; Postdoctoral Research Associate  The Tiny Cargo Company; Fralin Biomedical Research Institute at VTC, Terrance Hogue VP- Medical Affairs  Florica Therapeutics, Anna Kostrzak Research and Development Director Evora Biosciences, Anwar Hossain Senior Scientist- Neurosurgery Research MD Anderson Cancer Center, Gianluca Roma CEO  EV Therapeutics, Steven Jay Associate Professor of Bioengineering University of Maryland, AJ Bergman CFO Capricor Therapeutics, Linda Marban CEO  Capricor Therapeutics, Mei He Assistant Professor University of Florida, Shelley Hartmann CEO  Aegle Therapeutics, Chulhee Choi CEO ILIAS Biologics, David Greening Assistant Professor and Head of Molecular Proteomics; Director- Proteomics and Metabolomics Research Platform  Baker Heart and Diabetes Institute, Hadrien Lanvin CEO  Evora Bioscience, Maureen Merrifield SVP- Regulatory Affairs  Rion, Gi-Hoon Nam COO ShiftBio, Randolph Corteling VP- Research  ReNeuron Group, Seung Wook Oh CSO MDimune, Steve Stice CSO  Aruna Bio, Anna Duboff Associate Scientist II Codiak BioSciences, Gary Hao VP- Analytical Sciences Codiak BioSciences, Jahan Jowharchi CTO Rion, Subbaya Subramanian CSO EV Therapeutics, Christopher Paradise VP- Research and Development  Rion, Mari Mitrani CSO Organicell, Michael Bellio VP- Research and Manufacturing; Laboratory Director Organicell

Read More

View Less